Targeted sequencing with AmpliSeq for Illumina is a powerful tool for researchers and drug development professionals focusing on disease mechanisms and biomarker discovery.
This article provides a comprehensive analysis of the cost-effectiveness of implementing the AmpliSeq™ for Illumina® Childhood Cancer Panel in a clinical setting.
This article provides a comprehensive comparison of the AmpliSeq Childhood Cancer Panel against other next-generation sequencing (NGS) approaches for pediatric oncology.
This article provides a comprehensive analysis of the AmpliSeq™ for Illumina® Childhood Cancer Panel, a targeted next-generation sequencing (NGS) solution, for the molecular characterization of pediatric acute leukemia.
This article provides a detailed examination of the Limit of Detection (LOD) for the AmpliSeq™ for Illumina® Childhood Cancer Panel, a targeted NGS solution for pediatric malignancies.
This article provides a comprehensive evaluation of the reproducibility and reliability of the AmpliSeq for Illumina Childhood Cancer Panel, a targeted NGS solution for pediatric and young adult cancers.
This article provides a complete framework for researchers and drug development professionals to understand, prevent, and troubleshoot PCR contamination in AmpliSeq for Illumina next-generation sequencing workflows.
This guide provides researchers and clinical scientists with a comprehensive framework for calculating and optimizing sequencing coverage specifically for the AmpliSeq for Illumina Childhood Cancer Panel.
This article provides a comprehensive resource for researchers and scientists on optimizing the AmpliSeq for Illumina Childhood Cancer Panel for low-input and challenging samples, a common scenario in pediatric oncology...
This comprehensive guide details the essential quality control (QC) and troubleshooting protocols for AmpliSeq for Illumina libraries using the Agilent BioAnalyzer and Fragment Analyzer systems.